| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.tridentlifeline.com | |
| Market Cap | 189.74 Cr. | |
| Enterprise Value(EV) | 192.67 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 5.23 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 31.54 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 40.60 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 4.06 | Calculated using Price: 165.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.15 Cr. | 11,499,200 Shares |
| FaceValue | 10 | |
| About Trident Lifeline Ltd. | ||
| The company is engaged in the manufacturing and marketing of quality finished dosages. It is one of the fastest growing pharmaceutical companies in the SME segment providing unprecedented quality of healthcare products. It deals in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. | ||
| 1 Day |
|
|
| 1 Week |
|
+6.01% |
| 1 Month |
|
+10.0% |
| 3 Month |
|
-17.09% |
| 6 Month |
|
-9.64% |
| 1 Year |
|
+12.44% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 2 years | 2022-03 | 2023-03 | |
| Return on Equity (%) | 83.23 | 24.05 | |
| Return on Capital Employed (%) | 43.21 | 24.32 | |
| Return on Assets (%) | 30.72 | 16.83 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 5 | 46 | 49 | |
| Non Curr. Liab. | 0 | 2 | 2 | |
| Curr. Liab. | 8 | 11 | 12 | |
| Minority Int. | ||||
| Equity & Liab. | 13 | 59 | 63 | |
| Non Curr. Assets | 2 | 9 | 15 | |
| Curr. Assets | 11 | 49 | 48 | |
| Misc. Exp. not W/O | 0 | 0 | ||
| Total Assets | 13 | 59 | 63 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 22 | 32 | |
| Other Income | 1 | 1 | |
| Total Income | 22 | 33 | |
| Total Expenditure | -19 | -25 | |
| PBIDT | 3 | 7 | |
| Interest | 0 | 0 | |
| Depreciation | 0 | 0 | |
| Taxation | 1 | -1 | |
| Exceptional Items | |||
| PAT | 4 | 6 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 4 | 6 | |
| Adjusted EPS | 5 | 5 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -17 | |
| Cash Fr. Inv. | 0 | -7 | |
| Cash Fr. Finan. | 1 | 38 | |
| Net Change | 0 | 14 | |
| Cash & Cash Eqvt | 0 | 14 |
|
Fri, 26 Apr 2024
Announcement Under Reg 30 Of LODR - Commissioning Of Manufacturing Facilities Through Its Subsidiary Trident Lifeline Limited has commissioned manufacturing facilities through its subsidiary Company. More details are as per attached intimation. |
|
Sun, 21 Apr 2024
Update on board meeting The Board Meeting to be held on 22/04/2024 has been revised to 27/04/2024 The Board Meeting to be held on 22/04/2024 has been rescheduled to 27/04/2024 |
|
Mon, 15 Apr 2024
Announcement under Regulation 30 (LODR)-Updates on Acquisition Pursuant to Regulation 30 of SEBI(LODR) Regulations 2015 we wish to hereby inform that the Ministry of Corporate Affairs has approved incorporation of TLL ELEMENTS PRIVATE LIMITED (CIN: U20237GJ2024PTC150636) on 15th April 2024 and has issued a Certificate of Incorporation for the same at 05:25 p.m. |
| Thu, 25 Apr 2024 |
High Delivery Percentage
|
Opening at Low
|
Closing Below Previous Low
|
High Increase in 1 Month
|
High Decrease in 3 Months
|
